心理药物的ABC:药物发现的临床前路线图
Alex C Kwan1, John R Mantsch2, John D McCorvy3
1Meinig School of Biomedical Engineering, Cornell University, Ithaca, NY 14850, USA.
Trends in pharmacological sciences
|August 28, 2025
概括
开发下一代精神药物治疗精神疾病需要一个框架来评估受体选择性和治疗效果. 信号传导,行为分析和神经重塑的进步是这一过程的关键.
科学领域:
- 神经科学
- 心理药理学
- 药物发现
背景情况:
- 越来越多的人对精神障碍药物感兴趣.
- 识别具有理想受体选择性和治疗功效的下一代类型的挑战.
- 最近在偏向信号传导,行为表型,神经重塑和基因表达方面的进展.
研究的目的:
- 概述一种评估迷幻药和非幻觉性血清素2A (5-HT2A) 受体激活剂的框架.
- 批判性地检查当前评估激烈性,行为和细胞可塑性的方法.
- 突出人类翻译的新技术.
主要方法:
- 审查目前评估迷幻药物的方法.
- 对激动剂诱导的偏差信号传导的评估.
- 通过自动化视频分析进行高内容行为表型.
- 对药物引起的结构性神经重塑和活动依赖基因表达的分析.
主要成果:
- 提出了一个评估迷幻药和5-HT2A激动剂的框架.
- 目前用于评估激烈性,行为和可塑性的方法得到了批判性检查.
- 突出了人类翻译潜力的新技术.
结论:
- 一个有效的迷幻药物发现管道必须与实验目标保持一致.
- 结合多种方法对于成功开发迷幻药物至关重要.
- 拟议的框架有助于对新型迷幻药类药物的系统评估.
更多相关视频
11:27The Use of Pharmacological-challenge fMRI in Pre-clinical Research: Application to the 5-HT System
Published on: April 25, 2012
15.5K
11:44Cellular Membrane Affinity Chromatography Columns to Identify Specialized Plant Metabolites Interacting with Immobilized Tropomyosin Kinase Receptor B
Published on: January 19, 2022
2.6K
相关概念视频
Drug Discovery: Overview
8.7K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
8.7K
Preclinical Development: Overview
4.8K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.8K
CNS Stimulants: Psychedelic Agents
241
Hallucinogens, also known as psychedelic drugs, are a class of substances known for their ability to alter perception, cognition, and emotions. Despite their profound effects on the mind, these drugs are non-addictive, setting them apart from many other abused substances. The mechanism of action of these drugs lies in their impact on the 5-HT2A receptor in the brain. Upon activation, this receptor couples to Gq-type G proteins, triggering a cascade that releases intracellular calcium. This...
241
Hallucinogens and Psychedelics
282
Hallucinogens are psychoactive substances that profoundly alter perceptual experiences, generating unreal visual and sensory images. Often referred to as psychedelic drugs — a term derived from the Greek words "psyche" (mind) and "delos" (revealing) — these substances include marijuana and lysergic acid diethylamide (LSD), among others. These drugs vary in intensity and effects.
Marijuana, derived from the dried leaves and flowers of the hemp plant, contains...
Marijuana, derived from the dried leaves and flowers of the hemp plant, contains...
282
An Overview of Psychoactive Drugs
294
Psychoactive drugs impact brain function, influencing perception, mood, consciousness, cognition, and behavior. These substances are grouped based on their effects and the mechanisms by which they act.
Stimulants such as cocaine, amphetamines, and nicotine enhance brain activity, leading to increased alertness, attention, and energy. These drugs typically raise heart rate, blood pressure, and body temperature. While they can induce feelings of euphoria, their misuse can result in severe health...
Stimulants such as cocaine, amphetamines, and nicotine enhance brain activity, leading to increased alertness, attention, and energy. These drugs typically raise heart rate, blood pressure, and body temperature. While they can induce feelings of euphoria, their misuse can result in severe health...
294
Drug Administration and Therapy Phases: Overview
738
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
738
